(Q50888350)
Statements
Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. (English)
1 reference
Christopher M
1 reference
Hew FL
1 reference
Oakley M
1 reference
Rantzau C
1 reference
Alford F
1 reference
1 May 1998
1 reference
83
1 reference
5
1 reference
1668-1681
1 reference